Moderna | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
Adcock Ingram Holdings ZAR 2.53B 85.57M 2024-06
Agios Pharmaceuticals USD 81.16M 38.3M 2024-12
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Amgen USD 23.1B 2.79B 2024-12
Arrowhead Research USD 93.76M 9.41M 2024-12
Biogen USD 5.53B 103.8M 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Celltrion KRW 3.03T 141.48B 2024-09
Cspc Pharmaceutical CNY 10.44B 252.73M 2024-06
Dianthus Therapeutics USD 15.71M 5.68M 2024-09
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
Incyte USD 1.64B 140.2M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
Kangmei Pharma CNY 4.91B 208.41M 2024-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 272.46M 81.21M 2024-06
Malin Corporation EUR 500K 500K 2024-06
Moderna USD 2.21B 5M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Pharma Mar EUR 82.69M 6.75M 2024-12
Qiagen NV USD 543.63M 584.94M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Sartorius EUR 977M 116.3M 2024-09
Sino Biopharmaceutical CNY 21.95B 657.56M 2024-06
Tilray USD 278.52M 15.02M 2024-11
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
United Therapeutics USD 738.1M 135.3M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Zz Pientze Pharmaceu 3.1B 569.38M 2024-09



Moderna Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.